Name: Path to Prosperity: Rare disease patients find hope through China's medical insurance
Uploaded: 2025-12-15T12:41:02+08:00
Duration: 3 min 26 s
Description: Yang Qian, 23, lives with Fabry disease, a rare genetic disorder that causes a deficiency of alpha-galactosidase. In 2020, the drug Replagal became available in China, costing around $1,700 per box. By 2021, it was included in China's national medical

Language

RSS

Newsletters

Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

03:27

Yang Qian, 23, lives with Fabry disease, a rare genetic disorder that causes a deficiency of alpha-galactosidase. In 2020, the drug Replagal became available in China, costing around $1,700 per box. By 2021, it was included in China's national medical insurance catalog – cutting the price to $430 per box. CGTN follows Yang to see how China has built the world's largest health safety net, ensuring that no one is left behind.

Open in CGTN APP for better experience

Search Trends